scholarly article | Q13442814 |
P50 | author | Ruth A Karron | Q92344448 |
P2093 | author name string | Wendy Chen | |
Ram Yogev | |||
David P Greenberg | |||
Paul M Mendelman | |||
Sylvia H Yeh | |||
Mark M Blatter | |||
Min-Shi Lee | |||
Keith S Reisinger | |||
Joel I Ward | |||
Julie M Cordova | |||
Kathleen L Coelingh | |||
Marilyn J August | |||
Robert E Walker | |||
Chithra Sangli | |||
Lane Eubank | |||
Harshvardhan B Mehta | |||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | infancy stage | Q49257364 |
P304 | page(s) | 1116-1122 | |
P577 | publication date | 2005-02-22 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy | |
P478 | volume | 191 |
Q37468212 | A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates |
Q30229074 | Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus |
Q42637687 | Characterization of a parainfluenza virus isolated from a bottlenose dolphin (Tursiops truncatus). |
Q35751725 | Comparing the immune response to a novel intranasal nanoparticle PLGA vaccine and a commercial BPI3V vaccine in dairy calves |
Q50619591 | Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults. |
Q37075237 | Differential gender response to respiratory infections and to the protective effect of breast milk in preterm infants |
Q37164704 | Enterovirus 71 maternal antibodies in infants, Taiwan |
Q37247449 | Experimental infection of adults with recombinant wild-type human metapneumovirus |
Q36898701 | Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates |
Q45351582 | Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccine |
Q59358405 | Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques |
Q56894869 | Progress in respiratory virus vaccine development |
Q34209872 | Progress in the development of human parainfluenza virus vaccines |
Q38008607 | Recent developments with live-attenuated recombinant paramyxovirus vaccines |
Q34175747 | Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1 |
Q37470206 | Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children |
Q30235334 | The Role of Human Parainfluenza Virus Infections in the Immunopathology of the Respiratory Tract. |
Q36617225 | The cell biology of acute childhood respiratory disease: therapeutic implications |
Q47555408 | Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles |
Q24201977 | Vaccines for the common cold |
Q38682527 | Vaccines for the common cold |
Search more.